Holen Sie sich die Stockscreener-App
90.98
2.14%
-1.99
Handel nachbörslich:
91.00
0.02
+0.02%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$92.97
Offen:
$92.67
24-Stunden-Volumen:
9.72M
Relative Volume:
1.21
Marktkapitalisierung:
$116.08B
Einnahmen:
$407.94B
Nettoeinkommen (Verlust:
$2.90B
KGV:
39.95
EPS:
2.2771
Netto-Cashflow:
$7.39B
1W Leistung:
-2.44%
1M Leistung:
+8.44%
6M Leistung:
+13.22%
1J Leistung:
+44.92%
1-Tages-Spanne:
$90.57
$93.58
1-Wochen-Bereich:
$90.57
$94.17
52-Wochen-Spanne:
$58.50
$98.43
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
90.98 | 118.62B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
380.31 | 347.39B | 449.71B | 12.81B | 19.67B | 13.24 |
ELV
Elevance Health Inc
|
393.19 | 85.29B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
277.40 | 75.21B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
305.42 | 37.06B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
CVS Health Corp. stock: CVS Caremark coverage shift lifts attention - AD HOC NEWS
Inside CVS Pharmacy: How the Chain Shapes Everyday Care - AD HOC NEWS
Savant Capital LLC Sells 35,002 Shares of CVS Health Corporation $CVS - MarketBeat
Kingsview Wealth Management LLC Trims Position in CVS Health Corporation $CVS - MarketBeat
CVS Health AI Moves Highlight Prescription Safety And Valuation Debate - Yahoo Finance
LLY Stock Hits All-Time High — Is CVS Coverage Boost For Zepbound Driving Gains? - Stocktwits
Triglav Investments D.O.O. Decreases Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Norges Bank Makes New Investment in CVS Health Corporation $CVS - MarketBeat
Jupiter Asset Management Ltd. Reduces Holdings in CVS Health Corporation $CVS - MarketBeat
Ilmarinen Mutual Pension Insurance Co Takes $2.94 Million Position in CVS Health Corporation $CVS - MarketBeat
Fideuram Asset Management Ireland dac Purchases New Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Bought by Foundations Investment Advisors LLC - MarketBeat
CVS Health Corp. stock underperforms Friday when compared to competitors - MarketWatch
CVS Health embeds AI into pharmacy dispensing - Chain Store Age
CVS Health Corp. stock (US1266501006): GLP-1 coverage expansion and AI award in focus - AD HOC NEWS
Helping Medicare members improve access to care, one call at a time - CVS Health
Aetna Better Health(R) of West Virginia Opens New Community Resource Center in Clarksburg - ACCESS Newswire
AI helps CVS pharmacists cut delays, earn Newsweek safety award - Stock Titan
151,486 Shares in CVS Health Corporation $CVS Bought by United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund - MarketBeat
CVS Health Corporation $CVS Shares Sold by National Pension Service - MarketBeat
Aetna launches Aetna Mental Health On Demand to provide real time access to care and ongoing support - CVS Health
Geode Capital Management LLC Acquires 52,506 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Stock Price, Quote & Chart | CVS HEALTH CORP (NYSE:CVS) - ChartMill
Glenview Capital Keeps CVS Health (CVS) Among Top Holdings - Insider Monkey
Rhenman & Partners Asset Management AB's CVS Health Corp(CVS) Holding History - GuruFocus
Need help fast? Aetna’s new service links you to a clinician in 13 seconds - Stock Titan
How Safe Is CVS Health's Dividend? - Yahoo Finance
How Safe Is CVS Health's Dividend? - The Motley Fool
CVS returns Zepbound to drug plans after Lilly slashes price - MSN
H1 secures $40M from CVS, proving SaaS startups can still attract investment - TechCrunch
CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo - Fierce Pharma
H1 Receives $40M Investment in Round Led by CVS Health Ventures - The Manila Times
CVS Health streamlines healthcare call center interactions - Chain Store Age
CVS Expands Access to Eli Lilly's Obesity Medicines - GuruFocus
CVS Acquired in Major Net Lease Portfolio Deal - GuruFocus
CVS Returns Zepbound to Drug Plans After Lilly Slashes Price - Bloomberg.com
CVS Restores Coverage for Eli Lilly's Zepbound (CVS) - GuruFocus
athenahealth, Aetna CVS Health, and Catalyst Health Group Recognized for Advancing Real-Time Clinical Data Exchange - Yahoo Finance
Eli Lilly stock gains after CVS adds Zepbound to drug list - Investing.com Australia
Eli Lilly Zepbound Returns to CVS Formulary, Pre-Market Shares Rise as Much as 2% - TradingKey
CVS brings back coverage for Lilly's obesity drug Zepbound - Reuters
World Investment Advisors Raises Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health to deliver faster, more personalized call center care for millions of members with Salesforce’s Agentforce Health - CVS Health
AI agents join CVS call centers for 185M people, 1.5M providers - Stock Titan
CVS brings back coverage for Lilly’s obesity drug Zepbound By Reuters - Investing.com
CVS Caremark to add Zepbound to commercial formularies - Investing.com
Integrity Alliance LLC. Buys 21,549 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Bleakley Financial Group LLC - MarketBeat
Pharmacies Beat Fla. Hospitals' Opioids Suit - Law360
CVS, Walgreens and Walmart defeat Florida hospitals' opioid lawsuit - Reuters
CVS Health Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
2.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):